Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
1.9
-105.00%
20%
—
-4.74%
20%
—
5 Years
Score1.9
Net Growth-105.00%
Net Trend20%
Net Income Consistency—
Rev Growth-4.74%
Rev Trend20%
Revenue Consistency—
MaxCyte Inc fundamental performance
Between 2021 and 2025, revenue declined from $ 33M to $ 33M and net income went from -$ 19M to -$ 44M. Revenue increased in 20% of the years measured; net income in 20%.
MaxCyte Inc currently holds a 5-year HDB Score of 1.9 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 1.27 | — |
1 Year2025-08-12 | $ 1.27 | 0.00% |
5 Years2021-08-12 | $ 16.00 | -92.06% |
All Time2021-07-30 | $ 17.00 | -92.53% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2021-07-30 |
|---|---|---|---|---|
| Price | $ 1.27 | $ 1.27 | $ 16.00 | $ 17.00 |
| Return | — | 0.00% | -92.06% | -92.53% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 32M | -$ 39M | $ 14M |
| 2025 | $ 33M | -$ 44M | $ 103M |
| 2024 | $ 38M | -$ 41M | $ 154M |
| 2023 | $ 41M | -$ 37M | $ 168M |
| 2022 | $ 44M | -$ 23M | $ 227M |
| IPO2021 | $ 33M | -$ 19M | $ 255M |
Explore beyond MXCT
You're looking at MaxCyte Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
